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Biochemical Studies of the
Tracheobronchial Epithelium
by Marc J. Mass* and David G. Kaufman*
Tracheobronchial epithelium has been a focus of intense investigation in the field of chemical
carcinogenesis. We have reviewed some biochemical investigations that have evolved through linkage with
carcinogenesis research. These areas of investigation have included kinetics of carcinogen metabolism,
identification ofcarcinogen metabolites, levels ofcarcinogen binding to DNA, and analysis ofcarcinogen-
DNA adducts. Such studies appear to have provided a reasonable explanation for the susceptibilities ofthe
respiratory tracts ofrats and hamsters to carcinogenesis by benzo(a)pyrene. Coinciding with the attempts
to understandthe initiation ofcarcinogenesis in the respiratory tract has also been amajorthrust aimed at
effecting its prevention both in humans and in animal models for human bronchogenic carcinoma. These
studies have concerned the effects ofderivatives ofvitamin A (retinoids) and their influence on normal cell
biology and biochemistry of this tissue. Recent investigations have included the effects of retinoid
deficiency on the synthesis of RNA and the identification of RNA species associated with this biological
state, and also have included the effects of retinoids on the synthesis of mucus-related glycoproteins.
Tracheal organ cultures from retinoid-deficient hamsters have been used successfully to indicate the
potency of synthetic retinoids by monitoring the reversal of squamous metaplasia. Techniques applied to
this tissue have also served to elucidate features of the metabolism of retinoic acid using high pressure
liquid chromatography. In brief, formidable strides have been made in biochemistry specific to this
important target tissue, despite the inability to acquire tracheobronchial epithelium in large quantities.
Introduction
The tracheobronchial epithelium is a primary inter-
face with the environment, its constituents and its
contaminants. It is, then, not surprising that this tissue
gives rise to more fatal malignancies than any other
tissue in the human body. Cancers of the respiratory
tract cause 14% of cancer deaths in women and 34% in
men (1). Because the vast majority oflung cancers are,
in reality, cancers of the cells lining the large airway
passages (2), a concerted effort has been directed at
achieving experimental models of human lung cancers.
The intratracheal instillation technique ofSaffiotti et al.
(3), the heterotopic tracheal graft model of Nettesheim
et al. (4) and the localized instillation technique of
Schreiber et al. (5) all produce cancers with histologic
similarities to human bronchogenic epidermoid car-
cinoma. This review will consider the development of
experimental methods and the pursuit of two lines of
investigation which have evolved from these experimen-
talmodels oflung cancer. The first ofthese investigative
issues concerns the activation of carcinogens in this
target tissue, and the second relates to the action of a
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class of agents, retinoids, that may have promising
cancer chemopreventive properties in this tissue.
We review here findings of some current investiga-
tions in which epithelial cells of the tracheobronchial
airwayshavebeenused as a source forvariousbiochemi-
calanalyses. These investigations haveincluded carcino-
gen metabolism, binding and adduct analysis, glycopro-
tein biosynthesis, RNA synthesis, bioassay ofretinoids
and retinoic acid metabolism.
Biochemical studies in the tracheobronchial epithe-
lium appear, upon first consideration, to be a rather
limited proposition because of the small quantity of
tissue that is available. However, the studies mentioned
below attest to the fact that it is possible to perform
some sophisticated analyses in this tissue.
Methods for Biochemical Study of
Tracheobronchial Epithelium
The tracheobronchial epithelium is far more difficult
to use for biochemical studies than solid organs. The
cells comprising this tissue are those which line the
major pulmonary airways as well as connective tissue,
smoothmuscle, andcartilage. Thosebiochemicalcharac-
teristics specific to the epithelial cells can be appreci-
ated ifthese cells can be separated from their support-
ing elements. Yet, such a procedure yields smallMASS AND KAUFMAN
quantities ofcells, using many animals, alarge expendi-
ture of time, and considerable cost. Nonetheless, bio-
chemical methods have been developed for studies with
this tissue (Table 1).
Initially, studies ofbiochemical processes utilized the
intacttracheain large laboratory animals. Wardell et al.
(6) studied tracheal mucus production in dogs by
collecting secretions from grafted tracheas. Excised
segments ofthetracheawereimplanted subcutaneously
to form closed pouches, or sewn such that the lumen of
the trachea communicated with the outside through a
tracheocutaneous fistula. Secretions werecollected from
Table 1. Examples of methods used for tracheobronchial
biochemistry.
Procedure
Isolation of epithelial cells
Mechanical isolation
Enzymatic dissociation
Isolation of cell components
Nuclei
Microsomes
Cell homogenates
Macromolecule isolation
DNA
RNA
Glycoproteins
Glycerolipids
Carcinogen metabolism
Carcinogen-DNA binding
BP
BP
BP
BP
BP
DMBA
Nitrosamines
TLC analysis
BA, 7-MeBA, BP
BP
DMBA
HPLC analysis
BP
BP
BP
BP
Carcinogen-nucleoside
adduct analysis
BP
BP
BP
Aflatoxin B1
DNA repair
Unscheduled synthesis
BP-DNA adduct removal
Retinoic acid metabolism
Species References
Hamster
Hamster
Rat, mouse, rabbit
Hamster
Hamster
Hamster
Hamster
Hamster
Hamster
Rat
Dog
Rabbit
Rat
Hamster
Rat
Bovine
Human
Mouse
Human
Human
Human, rat, hamster
Human, rat, hamster
Rat
Human
Hamster
Rat
Mouse
Bovine
Human
Hamster, rat, mouse
Human
Rat
Hamster
Hamster
(8,13)
(11,29)
(32)
(8)
(13)
(13,14,20)
(24)
(73,88)
(11,84,89,90)
(7,10,76,77)
(6)
(32,91)
(92)
(13,14,24,28)
(14,28)
(28,93)
(15,28,59)
(28)
(20)
(54)
(36)
(17-19
(44)
(20,28)
(13,14,28)
(14,17,28)
(28)
(93)
(59)
(28)
(55)
(94)
(33)
(34,35,37,80)
the heterotopically placed tracheas and analyzed.
Recently, studies ofglycoprotein biosynthesis by Clark
and Marchok (7) utilized a modification of this graft
technique but with rat tracheas. These investigators
were able to collect milligrams of tracheal mucus for
subsequent analyses.
Tb study subcellular and macromolecular elements
specifically originating from the epithelial cells, it was
necessary to have a technique to isolate these cells from
the rest of the trachea. Smith et al. (8) were able to
recover a tracheal cell population by scraping the
epitheliumfromthetrachealsurfaceofSyrianhamsters.
Nuclei isolated fromthe tracheal cells were morphologi-
cally intact and competent at the synthesis of RNA.
Based on earlier observations that tracheal organ
cultures could be maintained in vitro with reasonable
morphologic preservation, Kaufman et al. (9) showed
that excised hamster tracheas incorporated radioac-
tively labeled macromolecular precursors from culture
medium during relatively briefperiods ofincubation in
vitro. Precursors of protein, RNA and DNA were
incorporated into these macromolecules within tracheal
epithelial cells and were analyzed in cells scraped from
the tracheas after the incubation period. Autoradio-
graphic studies performed simultaneously with bio-
chemical studies showed that thymidine was largely
incorporated into basal cells, uridine was most actively
incorporated into the nuclei of basal cells and ciliated
cells, whereas leucine was most actively incorporated
into mucous cells. These initial studies also showed that
macromolecules could be sufficiently labeled in this
manner to permit more sophisticated biochemical
studies.
Subsequently, Bonannietal. (10,11)showedthatwhen
relatively stable macromolecularproducts such asglyco-
peptides were the object for study, such products could
be isolated from tracheal epithelial cells that were
enzymatically dissociated from the underlying support-
ive structures by incubation with hyaluronidase. Even
smaller quantities of tissue than those used above
apparently have been sufficient for studies of gel-
electrophoretic analyses of LDH isozymes in the bron-
chi of rats exposed intratracheally to benzo(a)pyrene
(BP). In these studies, bronchial mucosa was isolated
from rats by smearing the epithelium onto a slide,
freeze-drying the slide, and scraping off the epithelial
cell residue (12).
Thorough studies of carcinogen metabolism in tra-
cheobronchial epithelium also became feasible as the
result of organ culture of this tissue. Prolonged and
reproducible exposures of the epithelium directly to
carcinogens were possible, and since no other parts of
the respiratory tract were present, the specific features
ofmetabolism in this tissue could be evaluated. Studies
of carcinogen metabolism have progressed further
through the development ofmethods for preparation of
epithelial cell homogenates from this tissue and isola-
tion of microsomes. Typical kinetic evaluations of BP
monooxygenase have been feasible with microsomal
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fractions from rat and hamstertracheas (13,14), and the
activity of the monooxygenase was detectable in
homogenates of cells scraped from human bronchus
(15,16). Specific products of the biotransformation of
radiolabeled carcinogens have been separated and
identified by thin layerand high-pressure liquid chroma-
tography (13,14,17-23). The binding of the carcinogen
BP to DNA was quantitated in cells isolated from
hamster tracheas by the scraping technique (24). DNA
was purified from tracheal cells by phenol extraction,
solvent extraction of unreacted BP, enzymatic removal
ofprotein and RNA, followed by banding at equilibrium
in centrifugally generated CsCl gradients. These tech-
niques were applied to the isolation ofDNAfrom human
bronchial tissues (15,20,25-27). Though the quantities
of DNA isolated are often on the order of micrograms,
this has proven sufficient to allow BP-DNA adduct
analyses in a variety of species including hamsters,
rats, mice, bovines and humans (28).
With the advent ofcell culture techniques for respira-
tory epithelial cells (29-32), defined populations ofcells
from this tissue have been evaluated for their metabolic
characteristics with respect to BP (18). Recently, East-
man et al. (33) utilized hamster tracheal cells in
monolayer culture to perform the first reported studies
of repair of carcinogen-DNA adducts in respiratory
epithelial cells.
Sporn and colleagues (34-40) have been studying the
mechanism of action of retinoids in the respiratory
epithelium. Organ cultures of the tracheobronchial
epithelium from hamsters were found suitable as exqui-
sitely sensitive bioindicators ofthe potency ofretinoids.
Studies on the metabolism ofretinoic acid and its active
intermediates (34,35) have proceeded somewhat like
studies of carcinogen metabolism with metabolites of
retinoic acid extracted from culture medium by organic
solvents and analyzed by HPLC.
The preceding discussion of biochemical methods
employed for studies of tracheobronchial epithelium
indicates the progress that has been made in this areaof
biochemistry. The following two sections illlustrate
morethoroughly twoareas ofresearch onthebiochemis-
try of the tracheobronchial tract that have shown
notable progress.
Carcinogen Metabolism in
Tracheobronchial Epithelium
Biological Evidence of Metabolism of
Polynuclear Hydrocarbons in
Respiratory Epithelium of Rodents
The lung consists of at least 40 cell types (41). A
proportionately large share of these cells provides
structural support for lung architecture and lines the
capillary network which interfaces the air spaces to the
blood supply. It is the cells which line the trachea and
bronchi which are at manifestly greater risk for the
development oflung cancer, but the cells ofthe tracheo-
bronchial epithelium comprise a minority of the total
cell population within the lung. Studies of carcinogen
activation in whole lung homogenates or subcellular
fractions thereof, do not directly reveal the characteris-
tics of polynuclear hydrocarbons (PNH) metabolism in
the cells most vulnerable to carcinogens, the cells lining
the tracheobronchial airways.
BP, a ubiquitous carcinogen and constituent of ciga-
rette smoke, serves as amost well characterized marker
for the presence of PNH in the environment. Until
recently there has been little information acquired
concerning BP metabolism in respiratory tract tissues
where this agent may exert a carcinogenic effect
in vivo.
Wattenberg and Leong (42) in 1962 attempted to
identify and localize sites of PNH metabolism in frozen
sections ofrodent tissues using a histofluorescent assay
for "pyridine nucleotide dependent polycyclic hydrocar-
bon metabolizing systems" They were unable to demon-
strate that respiratory epithelium metabolized BP since
these cells lacked fluorescent characteristics of BP
metabolites, but metabolic capacity was observed in
alveolar walls. However, studies ofrespiratory carcino-
genesis by Saffiotti et al. (3) in which BP-ferric oxide
was administered intratracheally to hamsters implied
that the trachea and bronchi could metabolize or, at
least, respond to this carcinogen by virtue of the
development oftracheobronchial cancers following such
carcinogen treatments. Theoretically, enzymatic activa-
tion could have occurred elsewhere in the respiratory
tract and activated metabolites could have entered
tracheal or bronchial cells by diffusion. Alternatively,
pulmonary macrophages which scavenged the instilled
carcinogen-laden particulate material could have re-
leased active metabolites (43,44). More direct evidence
of the capacity for carcinogen metabolism in tracheal
epithelium was provided by Dirksen and Crocker (45)
and by Palekar et al. (46). These investigators observed
that tracheal organ cultures of rat or hamster main-
tained in medium containing 7,12-dimethylbenz(a)an-
thracene (DMBA), benz(a)anthracene (BA), BP, and
3-methylcholanthrene (MCA) exhibited morphologic
changes of hyperplasia, metaplasia and other general
cytotoxic reactions. This observation narrowed the
likely site of activation since other elements of the
respiratory tract were absent. The alterations in this
tissue, therefore, were most probably related to the
conversion of the PNH to toxic metabolites directly in
tracheal cells. These results have been reproduced and
extended in more recent years by Lane and Miller
(47,48), and by Mossman and Craighead (49) with BP
and MCA, respectively.
More biologically integrated studies of carcinogen
activation in respiratory epithelium began to explore
animal models for human lung cancer. Biochemical and
anatomic factors which contributed to susceptibility to
carcinogen-induced neoplasia in animals were character-
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ized and considered with respect to their relevence to
humans. Studies in hamsters with the BP-ferric oxide
model of Saffiotti et al. (3) demonstrated that the
trachea was an ideal target tissue for biochemical
investigations. Subsequent studies have used human
respiratory tissues in explant culture.
Carcinogen Metabolism and DNA Binding
in Rodent Respiratory Tissues
Kaufman et al. (24) gave the first biochemical evi-
dence ofthe capacity oftracheal epithelium to metabo-
lize BP Excised hamster tracheas were incubated in
tissue culture medium containing [3H]BP, and epithelial
cells were subsequently obtained by scraping the muco-
sal surface of tracheas and the DNA from these cells
was isolated and purified in CsCl gradients. The DNA
had radioactivity associated with it which resisted
repeated ether extraction and was therefore attributed
to covalently bound [3H]BP Prior treatment of ham-
sters with intratracheal BP-ferric oxide enhanced the
binding of [3H]BP to DNA in tracheal epithelial cells.
This observation demonstrated substrate inducible
metabolism, a feature of cytochrome P-450-mediated
reactions. That this enzyme complex was involved in
the carcinogen binding was confirmed by the observa-
tion that 7, 8-benzoflavone (7,8-BF) inhibited the bind-
ing of [3H]BP to DNA in tracheas from BP-ferric
oxide-pretreated animals but not in tracheas from
control animals. This flavone inhibits the metabolism of
PNH catalyzed by liver microsomes obtained from rats
pretreated with an intraperitoneal injection of MCA.
Autoradiographic analysis (15,27) demonstrated mor-
phologically that [3H]BP was bound to cytoplasmic and
nuclear constituents primarily in the epithelial cells.
The extent of binding of [3H]BP in these autoradio-
graphic studies was reduced by co-incubation with
7,8-BF; this findingwas consistent with the biochemical
studies.
Harris et al. (20) used a fluorometric assay (50) to
measure aryl hydrocarbon hydroxylase (AHH) activity
in homogenates of cells scraped from bronchial organ
cultures. The radiometric assay of Hayakawa and
Udenfriend (51) was used to measure metabolites
released intothe organ culture medium fromexplants of
bronchial epithelium (20,43). The fluorometric assay
sensitively measures phenolic products of BP metab-
olism, and the assay of Hayakawa and Udenfriend (51)
measures the production of tritiated water resulting
from oxygenated 3H-hydrocarbon metabolites which
have undergone NIH shift concomitantly with tritium
loss upon formation. These assays offered a measure of
the formation of BP phenols and quinones by tracheal
tissue with the greatest sensitivity then available.
These methods, however, did not permit the various
products to be distinguished; some products, for
example, dihydrodiols, retain tritium upon formation,
and their presence was undetected.
Pal et al. (22) were the first to separate the products
of metabolism of PNH to further characterize these
metabolic processes in tracheobronchial epithelium.
They showed that thin-layer chromatography (TLC)
could be used to separate and identify phenol and
dihydrodiol metabolites of BA, 7-MeBA, and BP pro-
duced by organ cultures of human bronchus and by rat
and hamster trachea. Cohen et al. (19) used organ
cultures of tracheas, bronchi and peripheral lung from
rats, hamsters and humans as well as isolated perfused
rat and hamster lung in studies of BP metabolism. BP
metabolites, separated by TLC showed qualitative simi-
larities in metabolite patterns between tissues and
species. Qualitative differences were found between
metabolism in hamster lung fragments and in tracheas
and bronchi; this generally and perhaps fortuitously
corresponded to the relative susceptibility of these
tissues to tumorigenesis by BP in these tissues. Al-
though a low level of BP metabolism was detected in
lung tissue, this was of uncertain significance because
early signs of necrosis (darkened nuclei) were seen in
histologic sections ofthe lungfragments, and this would
account for the low level of metabolism. In another
report, Cohen et al. (17) identified an ethyl acetate-
soluble conjugate between sulfate and monohydroxy BP
that was a major metabolite in organ cultures of
respiratory tissues. Despite the identification of prod-
ucts of metabolism, these observations offered only a
limited view of carcinogen metabolism in respiratory
tract tissues for two reasons. First, TLC methods
offered qualitative identification ofproducts but quanti-
tative measurements were not readily made. Second,
since the underlying microsomal metabolism had not
been evaluated, the pattern ofmetabolites, particularly
those conjugated forms released into the organ culture
medium, could notbe related to the primary products of
BP metabolism by microsomes.
The assay for BP metabolism developed by DePierre
et al. (52) quantitated all of the products formed with
great improvement in sensitivity and precision. This
offered the possibility for direct measurement of BP
metabolism by microsomes from tracheobronchial epi-
thelium. Microsomes were isolated by Mass and Kauf-
man (13,14) from epithelial cells scraped from rat or
hamster tracheas; the yield of microsomal protein was
about 5 to 10 ,ug per trachea. By using this more
sensitive radiometric assay, metabolism ofBP by micro-
somes from hamster tracheas was detectable; further-
more, Lineweaver-Burk plots were prepared and Km
and Vmax values were estimated. Preincubation of
tracheas with BP prior to isolation of microsomes
doubled the Vmax of the monooxygenase; nonetheless
the activity of tracheal microsomes was 50-fold lower
than the activity of microsomes from the livers of rats
pretreated with IP injections of MCA. Km values for
microsomes from hamsters fell between 1 and 2 ,uM,
suggesting that the monooxygenase has a high affinity
for BP Similar studies with microsomes from rat
tracheas never detected metabolism, presumably be-
cause the activity ofbenzopyrene monooxygenase in rat
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tracheal microsomes is below the limit of detection of
this assay. The activity was detected in 10,000g
supernatants ofrat tracheal cell homogenates, but only
if the trancheas were preincubated with BP prior to
cellular isolation. The metabolic activity of superna-
tants from rat and hamster tracheal cell homogenates
are compared in a Lineweaver-Burk plot. (Fig. 1) The
BP-induced component ofthe mixed-function oxidase in
rattracheal cells was halfthat ofhamsters; however, the
Km values, spanning the 1 to 2 ,uM range, were
essentially equivalent. Titration of 7,8-BF effects on
benzopyrene monoxygenase from 10,000g supernatants
of hamster tracheas (Fig. 2) showed results like those
previously seen for DNA binding (24). BP pretreatment
increasedthesensitivityofbenzopyrenemonooxygenase
to 7,8-BE
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FIGURE 1. Lineweaver-Burk plot for benzopyrene monooxygenase
activity in supernatants of tracheal epithelial cell homogenates
centrifuged at 10,000g: (A) BP-pretreated hamster tracheas: (B)
BP-pretreated rat tracheas. Ordinate expressed as min/pmole;
abscissa, inverse substrate concentration expressed as 1/p.M.
The adoption of HPLC analysis of metabolites pro-
duced by hamster trancheal microsomes showed that
about 50% of the metabolites produced by hamster
tracheal microsomes cochromatograph with quinone
derivatives ofBP (Fig. 3). BP-phenols (3-OH and 9-OH)
comprised the second major class of metabolites and
these were well separated from dihydrodiols (diols) of
BP, the next most prevalent class of oxygenated
products. Metabolites produced by microsomes isolated
from BP-induced rat tracheal organ cultures had HPLC
profiles that differed from those produced by hamster
tracheal microsomes (Fig. 4). Rat tracheal microsomes
produced almost exclusively 3-OH BP with only a
minute peak cochromatographing with the 9,10-diol of
BP
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FIGURE 2. Effect of7,8-BF onbenzopyrenemonooxygenase activity
in supernatants from 10,OOg centrifugation of hamster tracheal
epithelial cell homogenates. Incubation time was 5 min at 37°C;
concentration of [3H]BP was 5 ,uM.
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FIGURE 3. Metabolites produced by microsomes from BP-pretreated
hamster tracheas after 30 min incubation with [3H]BP and
cofactors at 370C. Separation by reverse-phase HPLC.
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FIGURE 4. Reverse-phase HPLC separation ofmetabolitesproduced
by rat tracheal microsomes isolated from BP-pretreated tracheas.
Microsomes were incubated for 30 min with [3H]BP and cofactors
at 37°C.
determine whether the observed differences be-
tween rat and hamster in the activity microsomes and
the distribution of products formed were reflected by
the metabolism in intact tracheal cells, further studies
ofmetabolism were done withtracheas in organ culture.
After rat and hamster tracheas had been incubated
with [3H]BP, a portion of the medium was extracted
with ethyl acetate/acetone and the remainder was
treated with P-glucuronidase and aryl sulfatase prior to
extraction. By comparing the metabolites extracted in
these two ways, it was possible to determine both the
quantities and proportions ofwater-soluble metabolites
released into the ethyl acetate/acetone-soluble phase by
the deconjugating enzymes. About 35% ofthe metabo-
lites released into the medium by organ cultures were
ethyl acetate/acetone-soluble, and the remainder were
water-soluble. Deconjugation by aryl sulfatase and
,B-glucuronidase released an additional 30% ofthe total
products; nearly 40% of the metabolites were still
water-soluble afterthe enzyme treatment. The metabo-
lites which were conjugated were mostly BP-phenols,
BP-quinones, 7,8-diol, and highly polar derivates, some
of which were polyhydroxylated (Fig. 5). The quantity
of9,10-diolwhich wasethylacetate/acetone-extractable
did not change after the enzyme treatment. Rat tra-
cheal organculturesproducedlessethylacetate/acetone-
and water-soluble metabolites per millgram oftracheal
tissue than did hamster tracheal organ cultures (a
total of 3.7 pmole/mg/24 hr and 7.8 pmole/mg/24 hr
for rat and hamster, respectively). The major ethyl
acetate/acetone-extractable metabolite was the 9,10-diol
(Fig. 6). BP-phenols and a peak which contains a
monohydroxy BPsulfateconjugate (BP-S04) comprised
the next most abundant group of metabolites. Treat-
ment of the medium with aryl sulfatase and ,B-glu-
curonidase released an additional 35%, but 43% of the
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FIGURE 5. Hamster tracheas were incubated with 1 ,uM [3H]BP for
24 hr and variously treated organ culture medium: (A) extracted
with ethyl acetate/acetone and organic solvent soluble metabolites
separated by reverse-phase HPLC; (0) exposed to 11 units ofaryl
sulfatase and 1000units of 3-glucuronidase atpH 5for2 hrpriorto
extraction with ethyl acetate/acetone and separation by HPLC.
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FIGURE 6. Rat tracheas were exposed to 1 ,uM [3H]BP in organ
culture medium for 24 hr: (A) radioactivity from ethyl acetate/
acetone extract ofmedium separated by reverse-phase HPLC; (0)
organ culture medium exposed to 11 and 1000 units of 3-glu-
curonidase and aryl sulfatase, respectively, and metabolites ex-
tracted with ethyl acetate/acetone, and separated by reverse-
phase HPLC.
radioactivity was stillwater-soluble. Enzyme treatment
of medium from rat tracheal organ cultures released
3-OH BP as the major microsomal metabolite with
lesser quantities of BP-quinones released. Virtually no
BP-tetrols were present in the culture media ( < 1.5
pmole), whereas hamster tracheas produced 15 pmole.
The ratio of ethyl acetate/ acetone-soluble metabolites
released from medium by aryl sulfatase and ,-glu-
9,10-DIO
II ~~~~~~~~~~~~3-OH
7,8-DIOL 9-OHI
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FIGURE 7. Comparison ofmetabolites produced by (A) hamster tra-
cheas or (0) rat tracheas after exposure of organ culture fluid to
P-glucuronidase and aryl sulfatase. The results have been normal-
ized for the weight of tissue utilized in the incubation.
Table 2. Comparison of metabolites produced by rat and hamster
tracheal organ cultures.
Metabolite produced,
pmole/mg tissue/24 hr Ratio
Metabolite Hamster Rat (hamster/rat)
Pre-tetrols 0.86 0.18 4.78
Tetrols 0.22 0.01 22.0
9,10-Diol 1.41 0.30 4.70
4,5-Diol 0.05 0.04 1.26
7,8-Diol 0.46 0.15 3.07
Quinones 0.45 0.30 1.50
9-OH 0.48 0.11 4.36
3-OH 0.61 0.56 1.09
curonidase varied from 1.09 to 22.0 for hamster versus
rat tracheas (Table 2). The greatest discrepancy in
ratios is that of BP-tetrol formation; hamster tracheas
produced 22-fold more BP-tetrols than did rat tracheas.
This difference in products is further amplified in
Figure 7.
In light ofdifferences in metabolism noted for rat and
hamster tracheas, studies of binding of BP to DNA of
tracheas in culture were performed to further compare
these two species. DNA was isolated from epithelial
cells and banded on isopyknic CsClgradients. The mean
binding level for rat tracheas was 1.55 x 10-4 pmole
bound/,ug DNA. A separate experiment to determine
the effect of a pretreatment with BP on binding levels
revealed a binding level of 1.23 x 10-4 pmole/,Lg DNA
in tracheas pretreated with BP whereas control tra-
cheas had a level of 0.91 x 10-4 pmole/,ug DNA. In
hamstertracheas BP-pretreatment resulted in agreater
than 2-fold increase in binding (16.9 x 10-4 versus 42.6
x 10-4 pmole/,g DNA) which is in substantial agree-
ment with the earlier study by Kaufman et al. (24). The
mean bindinglevel forhamstertracheas was 26.7 x 10-4
pmole/,ug DNA. The 17-fold greater binding to DNA in
hamster tracheas than rat tracheas was comparable to
the ratio ofBP-tetrol formation in these two species and
may explain the species specificity for BP-induced car-
cinogenesis in the tracheas of hamsters (14,53).
Carcinogen Metabolism and Binding in
Human Respiratory Tissues
A series of recent experiments have extended the
study of metabolism and the binding of the activated
carcinogen to cellular DNA to human bronchial tissue.
These studies were of obvious importance because the
ultimate goal of previous studies, realized in these
investigations, is knowledge of the metabolism of
carcinogens in the critical human target tissue. Harris
et al. (27) demonstrated that specimens of human
bronchus could catalyze the binding ofPNH to DNA of
epithelial cells in explant culture of human bronchus.
The specific activity of binding of 4 PNH [DMBA, BP,
MCA and dibenzanthracene (DBA)] to bronchial cell
DNA in two to four unique specimens was assessed and
had a mean of 40 pmole/10 mg DNA; however, the
specimens bound more DMBA and BP than MCA or
DBA (27). In a study ofthe levels ofbinding of BP and
DMBA assessed in 28 specimens of human bronchus,
the mean level for DMBA-DNA binding was 118
pmole/10 mg DNA and that ofBP-DNA binding was 38
pmole/10 mg DNA, indicating that DMBA was bound to
a significantly greater extent. The levels of binding of
BP to bronchial DNA were studied more intensively in
37 specimens from patients with or without lung cancer
(25). The specimens were obtained either after immedi-
ate autopsy or during surgery to ensure the viability of
the tissues. The tissues were placed in culture for 7 days
priorto the addition of[3H]BP to the culture medium to
reduce the contribution by any exogenous or endoge-
nousfactors which couldinfluencethe levels ofBP-DNA
binding (i.e., specimens from smokers, or those taking
medications). All tissues were resected from normal
segments of the bronchus when specimens from pa-
tients with lung cancer were used. The levels ofbinding
of BP to DNA in these specimens of human bronchus
varied by 75-fold. In these initial studies there was no
obvious relationship between levels ofbinding in speci-
mens from patients with or without lungcancer. A more
recent report (26) using 79 specimens showed a 150-fold
range of variation in BP-DNA binding. Interestingly,
when specimens from lung cancer patients were segre-
gated according to histologic type of the tumor, a
difference was noted. Binding levels were higher than
controls in specimens from patients with epidermoid
carcinoma, epidermoid combined with adenocarcinoma,
and in mucous differentiated cancers with a nonglan-
dular pattern. The mean binding level in specimens
from patients with glandular, mucous differentiated
cancers was not significantly different from controls.
The metabolism of both cyclic and acyclic N-nitro-
samines was assessed in human bronchial organ cul-
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tures and these compounds were found to be metabo-
lized to products which bound to cellular DNA (54). The
capacity of human bronchus to activate aflatoxin B1 to
derivatives which bind to DNA also was determined;
the values obtained were somewhat lower than with
BP (55).
The range ofvariation in levels ofcarcinogen binding
to human bronchus was similar to those observed with
other human tissues. There was a 99-fold variation in
the binding ofBP to DNA in cultured human esophagus
(56), 100-fold in colon (57) and 70-fold inhuman endome-
trium (58). The absolute values for the binding ofBP to
DNA in human tissues were highest in human bronchus
and esophagus, lower in endometrium, whereas human
colon bound approximately 1/10 the quantity of BP to
DNA than did bronchus. The mean binding level for
human bronchus (25 pmole/10 mg DNA) was close to
that seen for tracheas of Syrian golden hamsters in
culture (14). The factors which govern the levels and
variation in BP-DNA binding levels in human bronchus
have not been determined. The levels of binding were
induced by BA pretreatment and by BP itself, and the
bindingwastime- andtemperature-dependent (15). The
variation was apparently not related to the formation
of different BP-DNA adducts, since the major adduct
in bronchus, esophagus and colon is an adduct of (+)
7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)-
pyrene with guanine (28,56,57,59). Alikely determinant
of the levels of binding of BP to DNA is variations in
levels and species of cytochrome P-450. It has been
observed that the total metabolic capacity for BP in
microsomes from human lungs vary (60), and Genta
(unpublished observations) (Fig. 8) has noted that
7,8-BF inhibits the binding of BP to DNA by 40% to
80% in bronchial specimens from nine individuals.
Compounds other than 7,8-BF (15), includingbutylated
hydroxytoluene (BHT) and nicotine, have been tested
fortheir effect on BP-DNAbinding in human bronchial
organ cultures. The antioxidant BHT is a potent inhibi-
torofbindingand reduced the level ofBP-DNAbinding
by 80% at a concentration of 2 ,uM. Nicotine, although
effective as an inhibitor of AHH in lung homogenates,
did not alter the level of binding in organ cultures of
human bronchus (15).
The metabolism of BP has been characterized by
HPLC in organ cultures of human bronchus. As with
rodent respiratory tissues, human bronchus produced
organic solvent-extractable and water-soluble metabo-
lites of BP (20,28). The ethyl acetate/acetone-soluble
components consisted of the 9,10-diol of BP and the
more polar triols and tetrols. Water-soluble metabolites
consisted ofsulfate, glucuronide, and glutathione conju-
gates of BP metabolites including BP-tetrols, the
9,10-diol, 4,5-diol, 7,8-diol, BP-quinones and BP-phenols
(28). Approximately half of the BP metabolites were
water-soluble, and half can be extracted with ethyl
acetate/acetone. When specimens from patients with or
without lung cancer were analyzed with respect to
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FIGURE 8. Inhibition by 7,8-BF ofbinding [3H]BP to DNA in organ
cultures of human bronchial epithelium from nine separate
specimens. Ordinate, ratio of specific activity of BP binding to
epithelial cell DNA in cultures with 7,8-BF added, to specific
activity determined in control cultures x 100; abscissa, case
identification number. Concentration of7,8-BF and [3H]BP were 2
,uM; incubation period was 24 hr. Data ofV M. Genta (unpublished
observations).
BP-metabolite profiles, theywereindistinguishable from
those from controls (20).
Effects of Retinoids on
Tracheobronchial Epithelium
A second area concerned with the biology and bio-
chemistry of tracheobronchial epithelium has been the
subject ofextensive study and progress in recent years.
This is the various effects of retinoids on this tissue.
The term "retinoids" has been used to describe the
natural forms ofvitamin A and the numerous functional
and structural analogs of vitamin A that have been
synthesized. Studies of retinoids have concerned bio-
chemical and biological studies ofretinoids, and investi-
gations concerning theirmetabolism and mechanisms of
action.
Relationship of Retinoids to Lung Cancer
The interest in the effects of retinoids on tracheo-
bronchial epithelium stems from the observations of
Saffiotti et al. (61) that administration oflarge doses of
vitaminAtohamsterspreviouslytreatedintratracheally
with BP-ferric oxide caused a marked reduction in the
number of respiratory tract tumors developing in this
animals. Concurrent studies with natural and subse-
quent studies with natural and artificial retinoids have
shown administration ofhigh doses ofretinoids to exert
an inhibitory or preventive effect on carcinogenesis in
several other organs (38). The subsequent record of
studies of the effects of retinoid treatment on respira-
tory carcinogenesis has been less consistent. Retinoids
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have been shown to inhibit respiratory carcinogeneis
(61-64) or to have no effect (65-67) or even to potentiate
respiratory carcinogenesis (68). The general interest in
retinoids generated by these studies led to consider-
ation ofthe effects ofthe vitamin A-deficient state with
regard to carcinogenesis. Genta et al. (69) explored the
effects of vitamin A deficiency on the binding of BP to
DNA in tracheas from vitamin A-deficient and normal
hamsters. Their observation, that vitamin A deficiency
enhanced the binding of BP to DNA, led to further
consideration of the effects of the vitamin A-deficient
state on carcinogenesis in this tissue. Nettesheim et al.
(41,62) evaluated this issue in rats maintained in
marginal, near-deficient vitamin A status. In compari-
son to rats provided aroughly normal vitamin A intake,
after intratracheal instillations ofMCA, the rats nearly
deficient in vitamin A developed a greatly increased
incidence of squamous nodules and of squamous carcino-
mas of the peripheral lung. This observation has been
supported by three epidemiologic studies which suggest
arelationship between vitamin A status and lung cancer
risk. Bjelke (70) conducted a prospective study in which
vitamin A intake levels were estimated from dietary
history surveys in a large Norwegian population and
found that lung cancer incidence was inversely corre-
lated with vitamin A intake. Mettlin et al. (71) esti-
mated vitamin A levels from vegetable consumption
surveys in a retrospective study on a separate popu-
lation. Again, a low estimated vitamin A intake was
associated with a higher relative risk for lung cancers
among subjects who smoked cigarettes. In a recent
prospective study (72) serum retinol levels were deter-
mined in alarge geographically defined population. Low
serum retinol levels were found among subjects who
subsequently developed an increased incidence of can-
cers including lung cancer. This correlation was also
consistent for the development of epithelial cancers of
various cell types in several tissues with a high inci-
dence of cancer.
RNA Metabolism and Inhibitors
of RNA Synthesis
Efforts have been made to determine the mechanism
of action of vitamin A in tracheal epithelium and to
elucidate the relationship between vitamin A and
carcinogenesis. On the macromolecular level, it was
hypothesized (9,24) thatthe morphologic manifestations
of vitamin A deficiency might be detectable as changes
in the types and classes ofproteins synthesized and that
this might be distinguished in the quantity and species
of their RNA precursors. To test this, tracheas were
excised from vitamin A-deficient or normal hamsters
and were incubated in organ culture medium containing
[3H]uridine. Epithelial cells were scraped fromtracheas
by the method of Smith et al. (8), whole cell RNA and
DNA was isolated by phenol extraction, and nucleic
acids were applied to agarose-acrylamide gels. In com-
parison to RNA species from normal tracheas, the
profile of RNA resulting from incorporated [3H]uridine
ingelsfromtrachealepithelial cellsofvitaminA-deficient
hamsters consistently had reduced levels ofcertain high
molecular weight RNA species (Fig. 9). This difference
in gel profiles could be reversed by treatment ofvitamin
A-deficient animals with retinyl acetate, restoring the
proportion of high molecular weight RNA species.
To determine if vitamin A deficiency affected the
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FIGURE 9. Electrophoreticprofileofspeciesofhighmolecularweight
RNA synthesized in vitro in tracheal epithelium of normal and
vitamin A-deficient hamsters. Distributions after labeling with
[3H]-uridine: (a) 30-min pulse; (b) 30-min pulse with additional
incubation for 30 min; (c) 30-min pulse with additional incubation
for 90 min; (0) RNA from tracheal epithelium vitamin A-deficient
hamsters; (e) RNA from tracheal epithelium ofvitamin A-normal
hamsters. From Kaufman et al. (88) with permission of the
authors and the American Association for the Advancement of
Science.
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processing or maturation of RNA, the effect of three
inhibitors of specific steps in RNA synthesis were
evaluated in organ culture. Toyocamycin, which inhibits
the maturation of 18S and 28S ribosomal RNA species
fromtheir45S precursor, actinomycin D and cx-amanitin,
inhibitors of RNA transcription and RNA polymerase
II, respectively, were used to further characterize the
effect of vitamin A deficiency. These compounds af-
fected the RNA profiles in a manner consistent with
their respective modes of action as described in other
systems (73), therefore excluding a specific role for
vitamin A in ribosomal RNA synthesis orprocessing. It
was concluded that the effect of vitamin A deficiency
was predominantly at the level of the heterogeneous
nuclear RNA; these species of RNA are presumed to
relate to messenger RNA. Since vitamin A deficiency is
manifested as a change in the state ofdifferentiation of
this tissue, from a mucus producing to a squamous
epithelium, it is plausible that an effect on messenger
RNA could underlie or reflect the vast phenotypic
changes seen in these cells.
Glycoprotein Biosynthesis
A major histologic change in respiratory epithelium
of rodents deficient in vitamin A is a loss of secreting
cells (74) whose secretory product is mucus, aglycopro-
tein mixture. Consequently, it was important to deter-
mine whether glycoprotein biosynthesis is altered in
tracheas of vitamin A-deficient animals. Using vitamin
A-deficient hamsters and rats, Bonanni et al. (10,11)
showed that the amount of a glycopeptide containing
fucose, mannose, hexosamines, galactose, and sialic
acids synthesized by the rodent tracheas in cultures was
dependent on vitamin A. In vitamin A-deficient rat
tracheas the level of synthesis was a third of that in
normal tracheas. More intensive studies of the mecha-
nism ofaction ofvitamin A in tissues such as liver (75),
which allow more sophisticated analyses, indicate that
vitamin A can act as a carrier in glycosyl transfer
reactions in membranes. Conversion of vitamin A to
retinyl phosphate apparently enables it to interact with
GDP-hexoses and link with the sugar moiety, releasing
GDP The suger-charged retinyl phosphate can transfer
sugar moieties to membrane-associated glycoproteins.
This mechanism for the mode of action of vitamin A
could explain the loss or reduction of glycoprotein
species in vitamin A deficiency (7,10,11,76,77) as the
result of a decreased capacity to manufacture mucus
glycoproteins with specific sugar moieties. Further
support for a role for vitamin A in glucoprotein synthe-
sis came from work by Clark and Marchok (76,77). They
reported that the type of mucins secreted by vitamin
A-deficient rat tracheas in culture had an altered
serine/glucosamine ratio.
Tracheal Organ Culture
for Bioassay of Retinoids
Because ofthe interest in retinoids as possible cancer
chemopreventive agents, it was necessary to develop a
means for determining the potency and toxicity of
retinoids in arelevant tissue. The ability ofvitamin A to
reverse morphologic alterations in vitamin A-deficient
tracheal epithelium within days of administration was
used by Sporn et al. (35,36,38-40,78) as an assay for
retinoid potency. Tracheas excised from animals de-
prived of vitamin A and maintained in a serum-free,
defined medium for 3 days were suitable for evaluating
the effects of retinoids added to the medium. If an
active retinoid such as retinoic acid were added to the
medium at levels as low as 10-11M, the squamous
metaplasia and keratohyaline granules which indicated
vitamin A deficiency diminished within 2 weeks, and
normal morphology was restored. A quantitative esti-
mate of efficacy was achieved by scoring a number of
replicate cultures for the percent of cultures in which
squamous metaplasia was reversed (Fig. 10). All-trans-
retinoic acid was the most potent natural derivative
of over 80 retinoids tested (36). Its 50% effective
dose was 3 x 10-11M (36). TIacheal epithelium in
organ culture was approximately 10,000 times more
sensitive to retinoic acid than were fibroblasts in cell
culture (79). This indicates the need to evaluate the
efficacy ofsuch specific agents in the tissue in which its
activity is relevant. Numerous retinoids have been
synthesized and evaluated in order to identify com-
pounds which are efficacious at low doses but are also
free from toxicity. It appears as if the presence of the
carboxylic acid, the alkene side chain, and the six-
membered P-cyclohexenyl ring are all important deter-
minants of the activity ofretinoids; however, no simple
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FIGURE 10. Bioassayforreversalofkeratinizationintrachealepithe-
lium in organ culture. Tracheas were incubated for 7 days in the
presenceofretinoidspriortoscoring. Dose-response curvesfor:(A),
retinoic acid; (A), retinyl acetate; (v), N-acetyl retinylamine; (o),
N-retinyl phthalimide. From Sporn et al. (40) with permission of
the authors and MacMillan Journals, Ltd.
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structure activity relationship is presently recognized.
Single substitutions in any ofthese regions can result in
a molecule with a markedly lowered biological activity.
Conversely, there now exist a number of synthetic
retinoids that are modified on both the ring and side
chain, yet display a potency greater or equal to that of
retinoic acid (36).
Metabolism of Retinoic Acid
The workofSporn and collaborators (34,35,37,80) has
elucidated another important aspect of the action of
retinoic acid: that retinoic acid, like many xenobiotics
and lipid-soluble compounds, can be metabolized in the
target tissue. For retinoic acid, this biotransformation
is linked to cytochrome P-450 containing mixed-function
oxidase since the metabolism is sensitive to a-naphtho-
flavone (7,8-BF), is NADPH-dependent, is inhibited by
carbon monoxide and it is inducible (37). It has pre-
viously been shown that retinoids act as competitive
inhibitors of the mixed-function oxidase in lung micro-
somal incubations using BP as the substrate (81).
Like many substrates forthe mixed-function oxidase,
retinoids can act as inducers for their own metabolism
by this enzyme complex. The magnitude ofinduction is
dependent upon the particular retinoid, and the extent
of induction varies from tissue to tissue. Interestingly,
the classical cytochrome P-450 and P-448 inducers,
phenobarbital and MCA, are ineffective as inducers of
retinoic acid metabolism.
Robertsetal. (37)assayedforretinoid-induced metab-
olism ofretinoic acid and derivatives invivo and invitro
usinghamsterkidney, liver, trachea, testisandintestine.
VitaminA-deficienthamstersweregivenretinoidsorally
for induction for 3 days, after which [3H]retinoic acid
wasinjected intrajugularly andtissue excised after4 hr.
The metabolism of retinoic acid was found to be
inducible invivo in liver, kidney, and intestine. Both the
testis and trachea had a high metabolic capacity for
retinoic acid; however, the activity was independent of
induction (i.e., was not inducible). Vitamin A-normal
animals were much more metabolically competent at
retinoic acid metabolism than the deficient animals,
indicating that some degree of induction is present in
the normal nutritional state.
The metabolism of retinoic acid has been character-
ized in detail in hamster tracheal organ cultures by
Frolik et al. (34,35). Two major metabolites were
detected after separation on reverse-phase HPLC.
Derivativization and subsequent mass spectral analysis
indicate that. one metabolite is 4-hydroxyretinoic acid
and the other is 4-oxoretinoic acid. When assayed in
tracheal organ culture, both ofthese compounds exhibit
little biological activity, and are on the order of 3% as
active in reversing keratinization as is retinoic acid.
Therefore, thesemetaboliteswerenotconsidered'active
intermediates" responsible for the activity ofretinoids,
and are likely to be products of inactivating pathways
for retinoids (34,35).
Conclusion
The preceding discussion has focused on two areas of
progress in studies ofthe biochemistry oftracheobron-
chial epithelium. As noted earlier, these topics were the
subjects of investigations because biological studies of
carcinogenesis in the rodent respiratory tract had
revealed that carcinogen metabolism and effects of
retinoids were important contributing factors. Within
the framework provided by the biological observation of
carcinogenesis studies, biochemical studies in both
areas could proceed in an effort to relate biochemical
mechanism to biological observation. Studies ofcarcino-
gen metabolism appear to have provided a mechanistic
explanation for the vast difference between two species
in susceptibility to tracheobronchial carcinogenesis by
BP (13,14). They also may be providing an explanation
forthe specific risk ofcertain individuals to lung cancer.
Furthermore, other studies in tracheobronchial epithe-
lium have provided initial or important contributions to
knowledge regarding the metabolism of BP-quinones
(21), the mechanism ofaction ofvitamin A (82,83), and
the alterations in RNA metabolism related to repro-
gramming ofcells for an altered state ofdifferentiation.
Several of these lines of investigation have proceeded
with technical methods that were highly sophisticated
and comparable to those used with othercells ortissues
where quantities ofmaterial were far less ofaproblem.
In addition to providing a record of progress, these
studies also illustrate a field of opportunity. Although
studies with tracheobronchial epithelium still may be
difficult because of the time and expense of obtaining
the tissue, once the tissue is available, a wide range of
biochemical investigations can be performed. Where a
specific problem must be evaluated directly in this
tissue, the methods exist for many types ofstudies and
the opportunity exists for further development. Initial
efforts were made based upon observations in respira-
tory carcinogenesis studies but the approach taken to
studythe biochemical features ofcarcinogenesis models
can be applied to investigations of the pathogenesis of
other diseases in this tissue.
Withthe development oftechniques forthe establish-
ment ofprimary cell cultures and lines ofbronchial and
tracheal epithelial cells (29-32,84-87), the opportunities
for the study of the biochemistry of the tracheobron-
chial epithelium may by greatly expanded. In addition
to the reduction in cost resulting from the use of
cultured cells ratherthan large numbers ofanimals, the
obtainment of cells is much easier and the cell popula-
tions are far more homogeneous than those collected
from animals. Furthermore, the availability ofcell lines
at various stages in the progression from normal to
malignant may provide exciting opportunities for study
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ofthe critical biochemical changes in premalignant and
malignant tracheobronchial epithelial cells.
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